Efforts to improve education on biosimilars are a start, but payer policies must catch up to ensure real change.
Mike Gladstone
Advertisement
Articles by Mike Gladstone
Advertisement
Latest Updated Articles
Payers Need to Make Effort for Improvements in BiosimilarsPublished: May 13th 2022 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Independent Pharmacies’ Current Hope for State, Federal PBM Reform
2
New Data Show Semaglutide’s Liver Benefits Not Exclusively Tied to Weight Loss
3
Register Today: December 2025 Total Pharmacy® Solutions Summit
4
Berberine Emerges as Front-Line Option for Managing Metabolic Syndromes
5
